XML 17 R18.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY
 3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY

11. STOCKHOLDERS’ EQUITY

 

Common Stock 

 

The Company had 8,726,045 shares of common stock, $0.001 par value per share, outstanding as of March 31, 2020 and December 31, 2019. 

 

Stock-Based Compensation 

 

A summary of stock option activity under the 2011 Long-Term Incentive Plan as of March 31, 2020, and changes during the three months ended March 31, 2020, are presented below: 

 

    Stock
Options		     Weighted average
exercise price		     Weighted
average remaining
contractual term		     Aggregate
intrinsic value		  
Outstanding as of January 1, 2020     379,800     $ 7.54       6.1     $ 22  
Granted     70,000       1.68                  
Exercised     —       —                  
Forfeited     (2,000 )     15.05                  
Outstanding as of March 31, 2020     447,800     $ 6.59       7.50     $ —  
Exercisable as of March 31, 2020     374,467     $ 7.50       6.90     $ —  

  

As of March 31, 2020, there were 225,867 shares available for future grants under the Company’s 2011 Long-Term Incentive Plan. 

 

Stock-based compensation expense recorded for the three months ended March 31, 2020 and 2019 was approximately $2 and $5, respectively. At March 31, 2020, the Company had total stock-based compensation expense remaining to be recognized in the consolidated statements of operations of approximately $1.